FT

AstraZeneca and Catalent defend Covid vaccine manufacturing process

Pharma giant and key supplier say ‘every batch’ is made to same standards amid EMA blood clot inquiry

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button